Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Nov;95(46):e5237.
doi: 10.1097/MD.0000000000005237.

Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report

Affiliations
Case Reports

Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia: Case report

Katerina Mensikova et al. Medicine (Baltimore). 2016 Nov.

Abstract

Background: Based on the results of recent multicenter clinical-pathological studies, it seems that the clinical heterogeneity of progressive supranuclear palsy (PSP) is much broader than previously thought. We will report 2 cases of patients with unusual manifestation of pathologically confirmed PSP.

Methods: Two female patients were diagnosed with the parkinsonian phenotype of multiple system atrophy (MSAP) according to current clinical diagnostic criteria at the ages of 55 and 60 years, respectively. The patients were followed up for the next 5 and 7 years. In both cases, a detailed neuropathological examination of the brain was conducted postmortem.

Results: In the first case, the overall pathological picture corresponded with the diagnosis of 4R tauopathy. In the second case, the brain pathology corresponded with a combination of 4R tauopathy and neocortical amyloidopathy.

Conclusion: Some of the main symptoms of MSA, such as cerebellar ataxia and orthostatic hypotension, are not rare parts of the clinical picture of PSP. PSP can thus be mistakenly diagnosed as MSA. In order to determine the most accurate clinical diagnosis of PSP, a revision of its current clinical diagnostic criteria seems appropriate.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Case 1. Horizontal FLAIR sequence showing rare small nonspecific (probably postischemic) white matter lesions (A). Sagittal T1-weighted MRI, showing near-normal shape of the brainstem (B). FLAIR = fluid-attenuated inversion recovery, MRI = magnetic resonance imaging.
Figure 2
Figure 2
Case 2. Horizontal FLAIR sequence showing mild supratentorial changes in the white matter of both hemispheres (A). Sagittal T1-weighted MRI showing the normal shape of the brain stem (B). FLAIR = fluid-attenuated inversion recovery, MRI = magnetic resonance imaging.
Figure 3
Figure 3
Case 1. Atrophy of the subthalamic nucleus (A). Spectrum of tau pathology in different brain regions: numerous threads, coiled bodies, and neurofibrillary tangles in the subthalamic region (AT8; B). A few tufted astrocytes in the basal ganglia (AT8; C). Neurofibrillary tangles in pigmented neurons of the substantia nigra (4RD; D). Original magnification: 100×.
Figure 4
Figure 4
Case 2. Numerous deposits of hyperphosphorylated tau protein positive with monoclonal antibody against DR4 subtype of tau protein in the substantia nigra, proving progressive supranuclear palsy (A). Neurofibrillary degenerative structures stained with monoclonal antibody against hyperphosphorylated tau protein showing Alzheimer disease–related neuropathology (B). Numerous deposits of hyperphosphorylated tau protein positive with monoclonal antibody against DR4 subtype of tau protein in the substantia nigra, original magnification 200× (C). Different morphology of amyloid plaques and cerebral amyloid angiopathy positive in immunohistochemical reaction with monoclonal antibody against amyloid-β-peptide (D).

Similar articles

Cited by

References

    1. Richardson JC, Steele J, Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of “heterogenous system degeneration”. Trans Am Neurol Assoc 1963; 88:25–29. - PubMed
    1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical supranuclear gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10:333–359. - PubMed
    1. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996; 55:97–105. - PubMed
    1. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128:1247–1258. - PubMed
    1. Williams DR, Holton JL, Strand K, et al. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 2007; 22:2235–2241. - PubMed

Publication types